KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Change in Accured Expenses (2017 - 2025)

Historic Change in Accured Expenses for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $3.3 million.

  • Guardant Health's Change in Accured Expenses rose 16844.19% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 13882.86%. This contributed to the annual value of -$2.8 million for FY2024, which is 15432.48% down from last year.
  • Latest data reveals that Guardant Health reported Change in Accured Expenses of $3.3 million as of Q3 2025, which was up 16844.19% from -$2.7 million recorded in Q2 2025.
  • Guardant Health's 5-year Change in Accured Expenses high stood at $24.3 million for Q3 2022, and its period low was -$28.3 million during Q2 2024.
  • Over the past 5 years, Guardant Health's median Change in Accured Expenses value was $3.3 million (recorded in 2025), while the average stood at $5.1 million.
  • Per our database at Business Quant, Guardant Health's Change in Accured Expenses soared by 64643.52% in 2022 and then crashed by 117635.19% in 2024.
  • Guardant Health's Change in Accured Expenses (Quarter) stood at $24.2 million in 2021, then plummeted by 43.83% to $13.6 million in 2022, then tumbled by 257.08% to -$21.4 million in 2023, then surged by 179.46% to $17.0 million in 2024, then tumbled by 80.72% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, -$2.7 million for Q2 2025, and -$1.5 million during Q1 2025.